SRRK · Scholar Rock Holding Corp
$49.37
+0.44 (+0.90%)
At close · Jul 28
Market Cap
$5.92B
Shares
119.83M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$49.37
Open$48.98
Day$47.34–49.52
52W$27.07–58.49
Avg vol 30d1.6M
Short int17.6M · 14.7% float · 16.2d
Short vol63%
Last earningsAug 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Aug 6, 2026
Scheduled
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
−1%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
71%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−10%
trailing
6-month return
+6%
trailing
YTD return
+12%
this year
Relative strength
−2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $50 › 200d $44 — 50d above 200d
Institutional flow
Distributing
56 of 280 funds reported for Jun 30 · net -10.2K sh shares · +11 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
14.69% of float · ▼ -4.2% MoM · 16.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
280 holders — near 3-yr high, broad support
Squeeze score
75
high risk · 0–100
Fundamentals
EPS growth
−33%
Y/Y
Free cash flow
$-300.6M
Balance sheet
$223.8M
net cash
Quant / Vol
risk profile
Volatility
62%
annualized · 1-yr
Max drawdown
−32%
past year
ATR
4.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
71%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $50 › 200d $44 — 50d above 200d
Institutional flow
Distributing
56 of 280 funds reported for Jun 30 · net -10.2K sh shares · +11 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
14.69% of float · ▼ -4.2% MoM · 16.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
280 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $27
Now $49 · 71%
52-wk high $58
vs 200-day avg +11%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SRRK
this stock
Scholar Rock Holding Corp
|
$5.92B | +12.1% | — | — | 14.7% |
|
ONC
BeOne Medicines Ltd.
|
$477.60B | +7.3% | +22179.2% | 971.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SRRK | -2.6% | -9.8% | +5.9% | -10.2% | +12.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -1.6% | -9.8% | -1.5% | -9.5% | +3.4% |
Key facts
CIK
1727196
CUSIP
80706P103
13F (30d)
51 filings
51 filers
Visit website
Investor relations